Characterization of patients with high somatic symptom severity

Recruiting

• Conditions: F45; K50; K51; F41; F32; Somatoform disorders; Crohn disease [regional enteritis]; Ulcerative colitis; Other anxiety disorders; Depressive episode

• Registration Number: DRKS00011685
• Lead Sponsor: niversitätsklinikum Heidelberg, Klinik für Allgemeine Innere Medizin und Psychosomatik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-02-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1300

Inclusion Criteria

Inclusion criteria for patients: high somatic symptom severity (SSS-8 = 8) OR Somatic Symptom Disorder (SSD-12) OR GAD-7 =10 OR PHQ-9 =10 OR IBD positiv
Inclusion criteria for healthy participants: low somatic symptom severity (SSS-8 <8), no Somatic Symptom Disorder (SSD-12), GAD-7 <10, PHQ-9 <10, IBD negativ, Charlson Comorbidity Index (CCI) = 0, no psychic or functional disorder according to patient self-report

Exclusion Criteria

Lacking language skills, psychosis, severe cognitive impairment, severe acute organic disease

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
crossectional observational study (descriptive and explorative): no primary outcome;<br>characterization and group comparisions according to symptom severity (physical: SSS-8, IBS-SSS; mental: GAD-7, PHQ-9, WI-7, PHQ panic module; general: VAS des EQ-5D), diagnostics (DSM-V: Somatic Symptom Disorder (SSD-12), ICD-10: somatoform disorder, functional disorder [ROME criteria]) and psychodynamic characteristics <br>(aversive childhood experiences: ACE-criteria, structure: OPD-SF, Metalizing: Mentalizing Questionnaire [MZQ], attachment: ECR-RD und RQ).